Ventrus Biosciences (VTUS)
Add to Watchlists Create an Alert
2.65
-0.11 -3.99%
NASDAQ
May 24, 5:00PM
BATS Real time
Currency in USD
Ventrus Biosciences Cash from Financing TTM:
4.897M for Dec. 31, 2012Ventrus Biosciences Historical Cash from Financing TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 4.897M |
| Sept. 30, 2012 | 4.911M |
| June 30, 2012 | 50.91M |
| March 31, 2012 | 46.41M |
| Dec. 31, 2011 | 47.49M |
| Sept. 30, 2011 | 62.99M |
| June 30, 2011 | 17.64M |
| March 31, 2011 | 18.18M |
| Dec. 31, 2010 | 19.70M |
| Sept. 30, 2010 | 5.366M |
| June 30, 2010 | 5.234M |
| March 31, 2010 | 5.009M |
| Dec. 31, 2009 | 3.552M |
About Cash From Financing (TTM)
VTUS Cash from Financing TTM Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | -5.623B |
| Tetraphase Pharmaceuticals | |
| Zoetis | -257.00M |
VTUS Cash from Financing TTM Rankings
| Overall |
78th percentile 1688 of 8009 |
| Sector |
62nd percentile 255 of 687 in Healthcare |
| Industry |
70th percentile 16 of 55 in Drug Manufacturers - Major |
VTUS Cash from Financing TTM Range, Past 5 Years
| Minimum | 3.552M | Dec 2009 |
| Maximum | 62.99M | Sep 2011 |
| Average | 22.48M |
